Oric Pharmaceuticals Stock Forward View - Simple Regression
| ORIC Stock | USD 10.09 0.10 1.00% |
Oric Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Oric Pharmaceuticals stock prices and determine the direction of Oric Pharmaceuticals's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Oric Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of Oric Pharmaceuticals' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Oric Pharmaceuticals hype-based prediction, you can estimate the value of Oric Pharmaceuticals from the perspective of Oric Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Oric Pharmaceuticals on the next trading day is expected to be 10.20 with a mean absolute deviation of 1.18 and the sum of the absolute errors of 72.02. Oric Pharmaceuticals after-hype prediction price | USD 10.09 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Oric Pharmaceuticals to cross-verify your projections. Oric Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Oric price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oric using various technical indicators. When you analyze Oric charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Oric Pharmaceuticals Simple Regression Price Forecast For the 18th of February 2026
Given 90 days horizon, the Simple Regression forecasted value of Oric Pharmaceuticals on the next trading day is expected to be 10.20 with a mean absolute deviation of 1.18, mean absolute percentage error of 1.89, and the sum of the absolute errors of 72.02.Please note that although there have been many attempts to predict Oric Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Oric Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Oric Pharmaceuticals Stock Forecast Pattern
| Backtest Oric Pharmaceuticals | Oric Pharmaceuticals Price Prediction | Research Analysis |
Oric Pharmaceuticals Forecasted Value
In the context of forecasting Oric Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Oric Pharmaceuticals' downside and upside margins for the forecasting period are 6.06 and 14.35, respectively. We have considered Oric Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Oric Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Oric Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.7447 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.1806 |
| MAPE | Mean absolute percentage error | 0.1209 |
| SAE | Sum of the absolute errors | 72.0189 |
Predictive Modules for Oric Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Oric Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Oric Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Oric Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Oric Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Oric Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Oric Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Oric Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Oric Pharmaceuticals' historical news coverage. Oric Pharmaceuticals' after-hype downside and upside margins for the prediction period are 5.91 and 14.27, respectively. We have considered Oric Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Oric Pharmaceuticals is somewhat reliable at this time. Analysis and calculation of next after-hype price of Oric Pharmaceuticals is based on 3 months time horizon.
Oric Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Oric Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Oric Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Oric Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.13 | 4.15 | 0.00 | 0.03 | 0 Events / Month | 2 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
10.09 | 10.09 | 1.00 |
|
Oric Pharmaceuticals Hype Timeline
Oric Pharmaceuticals is now traded for 10.09. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. Oric is forecasted to increase in value after the next headline, with the price projected to jump to 10.09 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is projected to be 1.0%, whereas the daily expected return is now at -0.13%. The volatility of related hype on Oric Pharmaceuticals is about 1985.65%, with the expected price after the next announcement by competition of 10.06. Net Loss for the year was (127.85 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out Historical Fundamental Analysis of Oric Pharmaceuticals to cross-verify your projections.Oric Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Oric Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Oric Pharmaceuticals' future price movements. Getting to know how Oric Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Oric Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AMLX | Amylyx Pharmaceuticals | 0.00 | 0 per month | 3.34 | 0 | 7.62 | (5.24) | 22.15 | |
| RLAY | Relay Therapeutics | 0.00 | 0 per month | 3.19 | 0.14 | 6.40 | (5.31) | 30.68 | |
| PGEN | Precigen | 0.02 | 12 per month | 4.18 | 0.09 | 6.97 | (7.02) | 18.66 | |
| NKTR | Nektar Therapeutics | (2.48) | 8 per month | 4.83 | 0.07 | 8.03 | (7.77) | 50.60 | |
| INBX | Inhibrx Biosciences | 0.00 | 0 per month | 4.04 | (0.01) | 5.36 | (5.44) | 17.82 | |
| SNDX | Syndax Pharmaceuticals | 0.00 | 0 per month | 1.95 | 0.1 | 5.68 | (3.57) | 18.37 | |
| TERN | Terns Pharmaceuticals | 0.00 | 0 per month | 2.74 | 0.12 | 6.88 | (5.57) | 43.41 | |
| ELVN | Enliven Therapeutics | 0.37 | 8 per month | 3.66 | 0.08 | 8.88 | (6.94) | 54.92 | |
| TRML | Tourmaline Bio | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ATAI | ATAI Life Sciences | 0.00 | 0 per month | 3.39 | 0 | 6.44 | (5.54) | 20.38 |
Other Forecasting Options for Oric Pharmaceuticals
For every potential investor in Oric, whether a beginner or expert, Oric Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Oric Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Oric. Basic forecasting techniques help filter out the noise by identifying Oric Pharmaceuticals' price trends.Oric Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oric Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Oric Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Oric Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Oric Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Oric Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oric Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Oric Pharmaceuticals stock market strength indicators, traders can identify Oric Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 31290.68 | |||
| Daily Balance Of Power | 0.2632 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 10.13 | |||
| Day Typical Price | 10.12 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | 0.1 |
Oric Pharmaceuticals Risk Indicators
The analysis of Oric Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Oric Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oric stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.03 | |||
| Standard Deviation | 4.15 | |||
| Variance | 17.2 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Oric Pharmaceuticals
The number of cover stories for Oric Pharmaceuticals depends on current market conditions and Oric Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Oric Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Oric Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Oric Pharmaceuticals Short Properties
Oric Pharmaceuticals' future price predictability will typically decrease when Oric Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Oric Pharmaceuticals often depends not only on the future outlook of the potential Oric Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oric Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 69.7 M | |
| Cash And Short Term Investments | 256 M |
Check out Historical Fundamental Analysis of Oric Pharmaceuticals to cross-verify your projections. For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Will Biotechnology sector continue expanding? Could Oric diversify its offerings? Factors like these will boost the valuation of Oric Pharmaceuticals. Anticipated expansion of Oric directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Oric Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Oric Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on Oric's balance sheet. Smart investors calculate Oric Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Oric Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Oric Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Oric Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Oric Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.